Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.327EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.129EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.224EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.618EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.458EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.244EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used